NASDAQ:CPHD - Cepheid Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$52.95
Today's Range$52.95 - $52.95
52-Week Range$25.09 - $53.91
VolumeN/A
Average Volume1.25 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Receive CPHD News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:CPHD
CUSIP15670R10
Phone+1-408-5414191

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Cepheid (NASDAQ:CPHD) Frequently Asked Questions

What is Cepheid's stock symbol?

Cepheid trades on the NASDAQ under the ticker symbol "CPHD."

How were Cepheid's earnings last quarter?

Cepheid (NASDAQ:CPHD) announced its quarterly earnings results on Thursday, July, 28th. The scientific and technical instruments company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.19. The scientific and technical instruments company earned $146 million during the quarter, compared to the consensus estimate of $145.82 million. The business's revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.06) earnings per share. View Cepheid's Earnings History.

Has Cepheid been receiving favorable news coverage?

News articles about CPHD stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cepheid earned a daily sentiment score of 1.0 on InfoTrie's scale. They also assigned news articles about the scientific and technical instruments company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future.

What other stocks do shareholders of Cepheid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cepheid investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Alibaba Group (BABA), Intel (INTC), Bristol-Myers Squibb (BMY), Celgene (CELG), Intercept Pharmaceuticals (ICPT), Illumina (ILMN), Baxter International (BAX) and Gilead Sciences (GILD).

How do I buy shares of Cepheid?

Shares of CPHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cepheid's official website?

The official website for Cepheid is http://www.cepheid.com.

How can I contact Cepheid?

Cepheid's mailing address is 904 E Caribbean Dr, SUNNYVALE, CA 94089-1189, United States. The scientific and technical instruments company can be reached via phone at +1-408-5414191.


MarketBeat Community Rating for Cepheid (NASDAQ CPHD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  481 (Vote Outperform)
Underperform Votes:  471 (Vote Underperform)
Total Votes:  952
MarketBeat's community ratings are surveys of what our community members think about Cepheid and other stocks. Vote "Outperform" if you believe CPHD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel